Middle East and Africa Syringe Market Growth and Analysis by 2027

The Middle East and Africa (MEA) syringe market is projected to reach US$ 1,450.40 million by 2027 from US$ 735.11 million in 2019. The market is estimated to grow at CAGR of 8.8% from 2020 to 2027.

The growth of the market is driven by the factors such as, growing number of chronic diseases and infectious diseases and increased adoption of injectable drugs. However, the market is likely to have negative impact due to growing cases of needle-stick injuries.

Chronic diseases, namely diabetes, cardiovascular disease, and cancer, are among the primary causes of death in adults. Infectious diseases are also the top causes of death in children and adults. The chronic and infectious diseases require continuous diagnosis using various medical tests requiring the use of syringes.

In the UAE, there is a high prevalence of diabetes. For instance, according to the International Diabetes Federation (IDF), in 2017, 17.3% of the UAE population between the ages of 20 and 79 have type 2 diabetes. Over 1 million people live with diabetes in the UAE, placing the country 15th worldwide for age-adjusted comparative prevalence. Additionally, diabetes is a regional affliction with Saudi Arabia, Bahrain, Kuwait, and Qatar, all featuring in the top twenty countries in terms of prevalence worldwide. Rapid economic growth, sedentary lifestyles, and unhealthy diets characteristic to the UAE are all risk factors, leading to the number of people with diabetes expected to double to 2.2 million by 2040. Many of these patients are advised regular intravenous administration of insulin, which increases the demand for syringes.

Infectious diseases are the second-top cause of deaths worldwide and are among the top causes of death in children under age 5. Similarly, there is a growing prevalence of infectious diseases in the UAE. For instance, according to the Department of Health -Abu Dhabi, in 2018, 46965 cases of communicable diseases was found in Abu Dhabi Emirate, Influenza (A, B, H1N1, & Unspecified): 22447, Chickenpox: 4290, Scabies: 2472, Measles (Rubeola): 1429. Many of these infectious diseases are treated by injectable vaccines, which increases the demand for syringes.

The growing adoption of injectable drugs to treat chronic and infectious diseases is expected to drive Syringe market growth during the forecast period.

Middle East and Africa (MEA) Syringe Market Revenue and Forecast to 2027 (US$ Mn)

Middle East and Africa (MEA) Syringe Market – Market Segmentation

By Syringes Type

• Luer Lock Syringes
• Glass Syringes
• Luer Slip Syringes
• Others

By Application

• Aesthetics
• Human Health
• Lab / Industrial
• Others

By Usability

• Sterilizable/Reusable Syringes
• Disposable Syringes

By End User

• Hospitals & Clinics
• Blood Collection Centers
• Diabetic Care Centers
• Others

By Country

• Saudi Arabia
• South Africa
• UAE

Company Profiles

• BD
• Baxter International Inc.
• Terumo Corporation
• Cardinal Health Inc
• Nipro
• RETRACTABLE TECHNOLOGIES, INC.
• B. Braun Melsungen AG

Middle East and Africa Syringe Report Scope